Emerging and Reemerging Infectious Diseases - Past, Present and Future

2007 ◽  
Vol 2 (2) ◽  
pp. 66-70 ◽  
Author(s):  
Yoshifumi Takeda ◽  
Keyword(s):  
Infectious Diseases ◽  
Emerging Infectious Diseases ◽  
World Health ◽  
Control Law ◽  
Global Response ◽  
The Us ◽  
The World ◽  
Us Government ◽  
Health Organization ◽  
Global Threat

The global threat of new infectious diseases first became widely recognized in the 1990s. The US government published a report on emerging and reemerging infectious diseases followed by the World Health Organization (WHO), which adopted the slogan "Emerging Infectious Diseases: Global Alert, Global Response" in 1997. Typical examples of the more than 30 infectious diseases emerging since 1970s are HIV/AIDS, Vibrio cholerae O139 infection, enterohemorrhagic Escherichia coli infection, severe acute respiratory syndrome (SARS), and avian influenza. The New Infectious Diseases Control Law enacted in Japan in 1999 was to control these emerging infectious diseases and the already existing ones.

Organization of restrictive quarantine measures to prevent especially dangerous infections

2020 ◽  
pp. 6-11
Author(s):  
Petr Ilyin
Keyword(s):  
Infectious Diseases ◽  
Clinical Symptoms ◽  
International Health ◽  
World Health ◽  
The World ◽  
History Of ◽  
Entire History ◽  
Health Organization ◽  
Former Ussr ◽  
Health Regulations

Especially dangerous infections (EDIs) belong to the conditionally labelled group of infectious diseases that pose an exceptional epidemic threat. They are highly contagious, rapidly spreading and capable of affecting wide sections of the population in the shortest possible time, they are characterized by the severity of clinical symptoms and high mortality rates. At the present stage, the term "especially dangerous infections" is used only in the territory of the countries of the former USSR, all over the world this concept is defined as "infectious diseases that pose an extreme threat to public health on an international scale." Over the entire history of human development, more people have died as a result of epidemics and pandemics than in all wars combined. The list of especially dangerous infections and measures to prevent their spread were fixed in the International Health Regulations (IHR), adopted at the 22nd session of the WHO's World Health Assembly on July 26, 1969. In 1970, at the 23rd session of the WHO's Assembly, typhus and relapsing fever were excluded from the list of quarantine infections. As amended in 1981, the list included only three diseases represented by plague, cholera and anthrax. However, now annual additions of new infections endemic to different parts of the earth to this list take place. To date, the World Health Organization (WHO) has already included more than 100 diseases in the list of especially dangerous infections.

scholarly journals Emerging zoonoses in Indonesia: implication for the future

2020 ◽  
Vol 39 (3) ◽  
pp. 151
Author(s):  
Toni Wandra
Keyword(s):  
Infectious Diseases ◽  
World Health Organization ◽  
Emerging Infectious Diseases ◽  
Zoonotic Diseases ◽  
World Health ◽  
Emerging Zoonoses ◽  
The Future ◽  
Health Organization

World Health Organization (WHO) defines zoonotic diseases (zoonoses) as those diseases and infections which are naturally transmitted between vertebrate animals and humans. More than 250 zoonoses have been described, over 60% of pathogens that cause diseases in humans are zoonoses of animals, and 75% of emerging infectious diseases. Most pandemics are caused by zoonoses.

scholarly journals SARS: Political Pathology of the First Post-Westphalian Pathogen

2003 ◽  
Vol 31 (4) ◽  
pp. 485-505 ◽  
Author(s):  
David P. Fidler
Keyword(s):  
Infectious Disease ◽  
Infectious Diseases ◽  
The United States ◽  
First Century ◽  
World Health ◽  
Health Security ◽  
The World ◽  
Twenty First Century ◽  
The Stability ◽  
Health Organization

In March 2003, the world discovered, again, that I humanity's battle with infectious diseases continues. The twenty-first century began with infectious diseases, especially HIV/AIDS, being discussed as threats to human rights, economic development, and national security. Bioterrorism in the United States in October 2001 increased concerns about pathogenic microbes. The global outbreak of severe acute respiratory syndrome (SARS) in the spring of 2003 kept the global infectious disease challenge at the forefront of world news for weeks. At its May 2003 annual meeting, the World Health organization (WHO) asserted that SARS is “the first severe infectious disease to emerge in the twenty-first century” and “poses a serious threat to global health security, the livelihood of populations, the functioning of health systems, and the stability and growth of economies.”

School Nurses on the Front Lines of Healthcare: Infectious Diseases Popularized in the News

2020 ◽  
Vol 35 (4) ◽  
pp. 212-216
Author(s):  
Lauren McNickle ◽  
Robert P. Olympia
Keyword(s):  
Infectious Diseases ◽  
School Nurses ◽  
World Health ◽  
Initial Assessment ◽  
Health Organizations ◽  
Public Health Organizations ◽  
The World ◽  
Control And Prevention ◽  
Life Threatening ◽  
Health Organization

School nurses may deal with students presenting with symptoms associated with infections popularized in the news. Although rare, the implications of missing or misdiagnosing these infections are potentially life-threatening and devastating. We present three students presenting with febrile illnesses associated with neurologic symptoms, a rash, and fatigue, focusing on the initial assessment and management of these students and their associated “hot topic” infection. The authors also discuss two public health organizations, Centers for Disease Control and Prevention (https://www.cdc.gov/) and the World Health Organization (https://www.who.int/), online references for the school nurse to research both emerging and common infectious diseases.

scholarly journals National Institute for the Infectious Diseases “L. Spallanzani” IRCCS. Recommendations for COVID-19 Clinical Management

2020 ◽  
Vol 12 (1) ◽  
Author(s):  
Emanuele Nicastri ◽  
Nicola Petrosillo ◽  
Tommaso Ascoli Bartoli ◽  
Luciana Lepore ◽  
Annalisa Mondi ◽  
...  
Keyword(s):  
Infectious Diseases ◽  
World Health ◽  
Expert Opinions ◽  
Respiratory Involvement ◽  
Health Authorities ◽  
Global Pandemic ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Affected Country

On January 9th, 2020, the “World Health Organization” (WHO) declared the identification, by Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 responsible of a diseases (COVID-19) ranging from asymptomatic cases to severe respiratory involvement. On March 9th, 2020, WHO declared COVID-19 a global pandemic. Italy is the second most affected country by COVID-19 infection after China. The “L. Spallanzani” National Institute for the Infectious Diseases, IRCCS has been the first Italian hospital to admit and manage patients affected by COVID-19. Hereby, we show our recommendations for the management of COVID-19 patients, based on very limited clinical evidences; these recomendations should be considered as expert opinions, which may be modified according to newly produced literature data. *for the INMI COVID-19 Treatment Group – ICOTREG Abdeddaim A, Agrati C, Albarello F, Antinori A, Ascoli Bartoli T, Baldini F, Bellagamba R, Bevilacqua N, Bibas M, Biava G, Boumis E, Busso D, Camici M, Capobianchi MR, Capone A, Caravella I, Cataldo A, Cerilli S, Chinello G, Cicalini S, Corpolongo A, Cristofaro M, D’Abramo A, Dantimi C, De Angelis G, De Palo MG, D’Offizi G, De Zottis F, Di Lorenzo R, Di Stefano F, Fusetti M, Galati V, Gagliardini R, Garotto G, Gebremeskel Tekle Saba, Giancola ML, Giansante F, Girardi E, Goletti D, Granata G, Greci MC, Grilli E, Grisetti S, Gualano G, Iacomi F, Iannicelli G, Ippolito G, Lepore L, Libertone R, Lionetti R, Liuzzi G, Loiacono L, Macchione M,  Marchioni L, Mariano A, Marini MC, Maritti M, Mastrobattista A, Mazzotta V, Mencarini P, Migliorisi-Ramazzini P, Mondi A, Montalbano M, Mosti S, Murachelli S, Musso M, Nicastri E, Noto P, Oliva A, Palazzolo C, Palmieri F, Pareo C, Petrone A, Pianura E, Pinnetti C, Pontarelli A, Puro V, Rianda A, Rosati S, Sampaolesi A, Santagata C, Scarcia D’Aprano S, Scarabello A, Schininà V, Scorzolini L, Stazi GV, Taibi C, Taglietti F, Tonnarini R, Topino S, Vergori A, Vincenzi L, Visco-Comandini U, Vittozzi P, Zaccarelli M, Zaccaro G.

scholarly journals Counterfeit drugs as a global threat to health

2011 ◽  
Vol 64 (5-6) ◽  
pp. 285-290 ◽  
Author(s):  
Svetlana Golocorbin-Kon ◽  
Momir Mikov
Keyword(s):  
World Health Organization ◽  
Health Professionals ◽  
World Health ◽  
Sources Of Information ◽  
Counterfeit Drugs ◽  
Counterfeit Medicines ◽  
The World ◽  
Health Organization ◽  
Global Threat ◽  
Many Sources

According to the World Health Organization, counterfeit medicines are medicines that are mislabeled deliberately and fraudulently regarding their identity and/or source. All kinds of medicines have been counterfeited, both branded and generic ones. Counterfeit medicines may include products containing correct or wrong ingredients; without active or with insufficiently or over-active ingredients, or with fake packaging. Many sources of information have been explored, including reports from the national medicine regulatory authorities, pharmaceutical companies and literature data. Since the time counterfeit drugs first appeared, they have become more sophisticated and more difficult to be detected. The World Health Organization estimate is that up to 1% of medicines available in the developed world are likely to be counterfeit. This figure rises to 10% globally, although in some developing countries it is 50%. The World Health Organization estimate is that 50% of medicines available via the internet are counterfeit. The knowledge about counterfeit drugs should be used to educate students of pharmacy and medicine, health professionals and patients. The most important players in campaign against counterfeit medicines are health professionals. Pharmacists and doctors should stay vigilant and report suspicious products, and consider counterfeits as a possible cause of adverse reactions or therapeutic failure. Patients should inform their pharmacists and doctors if they suspect any irregularity concerning their medication, if they experience side effects or a decrease in beneficial effect. The crucial step in the prevention of counterfeit medicines is to get supplied from reliable sources, i.e. licensed pharmacies.

scholarly journals Microscopic Examination Of Postcapillary Cerebral Venues In Hemorrhagic Stroke

2021 ◽  
Vol 03 (08) ◽  
pp. 69-73
Author(s):  
Khaidarov Nodir Kadyrovich ◽  
◽  
Shomurodov Kahramon Erkinovich ◽  
Kamalova Malika Ilhomovna ◽  
◽  
...  
Keyword(s):  
Hemorrhagic Stroke ◽  
Surgical Intervention ◽  
Neurological Complications ◽  
World Health ◽  
Timely Manner ◽  
Global Response ◽  
Adequate Treatment ◽  
The World ◽  
Circulatory Disorders ◽  
Health Organization

Hemorrhagic stroke among acute cerebral circulatory disorders is characterized by severe neurological complications and the need to choose between surgical intervention or therapeutic therapy. According to the World Health Organization (WHO)". Globally, stroke deaths will reach 7.8 million by 2030 unless an aggressive global response to the epidemic is put in place" 1. Subarachnoid haemorrhage, which accounts for half of the non-traumatic intracerebral haemorrhage, affects the most active and able-bodied population. The most important medical and social objectives are to monitor the course of the disease from the first hours after the onset of stroke, to prescribe adequate treatment in a timely manner, and to reduce mortality and disability rates [5,9].

scholarly journals The WHO Collaborating Centre for Biosafety in Microbiology

2008 ◽  
Vol 29 (2) ◽  
pp. 84
Author(s):  
Tony Della-Porta ◽  
Michael Catton
Keyword(s):  
Infectious Diseases ◽  
World Health Organization ◽  
Significant Role ◽  
World Health ◽  
Reference Laboratory ◽  
Raising Awareness ◽  
The World ◽  
Health Organization

The World Health Organization (WHO) Collaborating Centre for Biosafety in Microbiology has been established at the Victorian Infectious Diseases Reference Laboratory (VIDRL) for over 2 decades and played a significant role in the development of the WHO Laboratory Biosafety Manual and the WHO Biorisk Guidelines. It has also contributed to WHO?s international biosafety programmes and to the raising awareness of biosafety in Australia.

Sign in / Sign up

Export Citation Format

Share Document